CSIMarket
 




Organicell Regenerative Medicine Inc   (BPSR)
Other Ticker:  
 
 



BPSR Price to Cash Flow Ratio (Jan 31 2022) (Oct 31 2021) (Jul 31 2021)
Cash Flow Trailing 12 Months I. Quarter IV. Quarter III. Quarter
Price to Cash Flow (TTM) Ratio current            761.07            761.07            761.07            761.07            761.07
Cashflow TTM Y / Y Change - % - % - % - % - %
Cashflow Y / Y Change - % - % - % - % - %
Stock performance to date 10.09 % -41.35 % -58.86 %

Price to Cash Flow ratio Comment
Due to increase in Cash flow in I. Quarter, Organicell Regenerative Medicine Inc 's current Price to Cash Flow ratio is at 761.07.


What is Price to Cash Flow Ratio?
Valuation in Biotechnology & Pharmaceuticals Industry

Price to Cash Flow ratio Company Ranking
Within: No.
Industry #59
Sector #366
S&P 500 #1927






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com